0001388410-19-000152.txt : 20191119
0001388410-19-000152.hdr.sgml : 20191119
20191119171215
ACCESSION NUMBER: 0001388410-19-000152
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190701
FILED AS OF DATE: 20191119
DATE AS OF CHANGE: 20191119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ARENA PAUL R
CENTRAL INDEX KEY: 0001275657
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-52534
FILM NUMBER: 191232092
MAIL ADDRESS:
STREET 1: 1327 OCEAN AVE SUITE M
CITY: SANTA MONICA
STATE: CA
ZIP: 90401
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PARALLAX HEALTH SCIENCES, INC.
CENTRAL INDEX KEY: 0001388410
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000]
IRS NUMBER: 464733512
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1327 OCEAN AVENUE, SUITE M
CITY: SANTA MONICA
STATE: CA
ZIP: 90401
BUSINESS PHONE: 310-899-4442
MAIL ADDRESS:
STREET 1: 1327 OCEAN AVENUE, SUITE M
CITY: SANTA MONICA
STATE: CA
ZIP: 90401
FORMER COMPANY:
FORMER CONFORMED NAME: ENDEAVOR POWER CORP.
DATE OF NAME CHANGE: 20140110
FORMER COMPANY:
FORMER CONFORMED NAME: Endeavor Power Corp
DATE OF NAME CHANGE: 20090105
FORMER COMPANY:
FORMER CONFORMED NAME: Endeavor Uranium, Inc.
DATE OF NAME CHANGE: 20071113
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2019-07-01
0
0001388410
PARALLAX HEALTH SCIENCES, INC.
PRLX
0001275657
ARENA PAUL R
1327 OCEAN AVE SUITE M
SANTA MONICA
CA
90401
1
1
0
0
CEO, President
COMMON STOCK (RESTRICTED)
2019-07-01
5
A
0
E
2375000
0.001
A
7375000
D
COMMON STOCK (RESTRICTED)
2019-09-30
5
P
0
E
1600000
0.0625
A
8975000
D
WARRANTS
0.25
2019-09-30
5
A
0
E
1600000
0
A
2019-09-30
2022-09-30
COMMON STOCK
1600000
6645000
D
Granted pursuant to Employment Agreement dated July 1, 2017.
Total restricted stock grant 10,000,000 common shares, of which a total of 7,500,000 have vested, and 2,500,000 will vest upon positive earnings.
Issued in connection with a Securities Purchase Agreement dated September 30, 2019, for proceeds in the amount of $100,000, paid by way of reduction in accrued compensation.
Warrants granted in connection with Securities Purchase Agreement dated September 30, 2019.
PAUL R. ARENA
2019-11-19